SCHEMBL1016540

SCHEMBL1016540

O=C(C=CCN1CCOCC1)N1CCc2c(sc3ncnc(Nc4ccc5c(ccn5Cc5ccccn5)c4)c23)C1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.62
TNNI3K Q59H18 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016539 1.00 EGFR (0.62) EGFRTNNI3K
SCHEMBL1017061 0.94 EGFR (0.57) EGFR
SCHEMBL1017062 0.94 EGFR (0.57) EGFR
SCHEMBL1013639 0.92 EGFR (0.66) EGFR
SCHEMBL1013640 0.92 EGFR (0.66) EGFR
SCHEMBL1015981 0.90 EGFR (0.62) EGFR
SCHEMBL1015980 0.90 EGFR (0.62) EGFR
SCHEMBL1068057 0.88 EGFR (0.62) EGFR
SCHEMBL1068058 0.88 EGFR (0.62) EGFR
SCHEMBL1015258 0.88 EGFR (0.65) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001890-B1 TETRAHYDROPYRIDOTHIENOPYRIMIDINE COMPOUNDS AND USE FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS BAYER SCHERING PHARMA AG (DE) 2011-01-12 EP disclosed